http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View More Recent Stories
-
Akers Biosciences Appoints Former Congressman Rob Andrews to the Board
-
Akers Biosciences, Inc. Announces Adjournment of Annual Meeting to August 3, 2015
-
Akers Biosciences, Inc. Announces Adjournment of Annual Meeting to August 3, 2015
-
Akers Biosciences Updates on New Rapid Breath Ketone and Oxidative Stress Tests for Health and Wellness Industry
-
Akers Biosciences Updates on New Rapid Breath Ketone and Oxidative Stress Tests for Health and Wellness Industry
-
Akers Biosciences Presenting at US Investor Conference
-
Akers Biosciences Presenting at US Investor Conference
-
Financial Results for First Quarter 2015
-
Akers Biosciences Introduces New Rapid Breath Ketone and Oxidative Stress Tests to the Health and Wellness Industry
-
Akers Biosciences Introduces New Rapid Breath Ketone and Oxidative Stress Tests to the Health and Wellness Industry
-
Akers Biosciences Announces Conference Call to Discuss Its First Quarter 2015 Earnings
-
Akers Biosciences Announces Conference Call to Discuss Its First Quarter 2015 Earnings
-
Akers Biosciences Signs Agreement to Sell METRON(R) Breath Ketone Test Online, With Key Focus on Amazon Marketplace
-
Akers Biosciences Signs Agreement to Sell METRON(R) Breath Ketone Test Online, With Key Focus on Amazon Marketplace
-
Akers Biosciences Further Expands International Distribution of Flagship Rapid Test
-
Akers Bio Signs Distribution Agreement With ADS for U.S. Govt.
-
Akers Bio Signs Distribution Agreement With ADS for U.S. Govt.
-
Akers Biosciences Reports Earnings for Fiscal Year 2014
-
Akers Biosciences Reports Earnings for Fiscal Year 2014
-
Akers Announces Conference Call to Discuss Its Fourth Quarter and Full Year 2014 Earnings
-
Akers Announces Conference Call to Discuss Its Fourth Quarter and Full Year 2014 Earnings
-
Akers' Management System Certified to ISO 13485 (2003)
-
Akers Presenting at US Investor Conference
-
European Patent Granted for Akers' Rapid Blood Separation Technology
-
Akers Biosciences Announces $1 Million Initial Order to Supply PIFA Heparin/PF4 Products to China
-
Akers Biosciences Announces Conference Call to Discuss Its Third Quarter and Nine Months Financial Results
-
Akers Biosciences Announces Joint Venture to Market Rapid Diagnostic Tests in China
-
Akers Biosciences Announces $864,000 Sales Contract for Its Rapid Results Point of Care Cholesterol Test
-
Akers Appoints New Vice President of International Sales and Marketing to Build International Business
-
Akers Biosciences Signs Feasibility Study Deal With Konica Minolta to Develop Rapid Test to Aid Heart Attack Diagnoses
-
US Patent Granted for Akers' Breath Ketone Detection Device
-
Akers Biosciences Signs Agreement With Medline -- a Major US Distributor
-
Akers Biosciences Signs Agreement to Market Rapid Tests in India

